Related references
Note: Only part of the references are listed.Liquid compared with conventional cervical cytology - A systematic review and meta-analysis
Marc Arbyn et al.
OBSTETRICS AND GYNECOLOGY (2008)
Economic evaluation of human papillomavirus vaccination in the United Kingdom
Mark Jit et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3:: population based cohort study
Bjorn Strander et al.
BMJ-BRITISH MEDICAL JOURNAL (2007)
Human papillomavirus and cervical cancer
Mark Schiffman et al.
LANCET (2007)
Multiparameter calibration of a natural history model of cervical cancer
Jane J. Kim et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial
Guglielmo Ronco et al.
BRITISH MEDICAL JOURNAL (2007)
A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion
Martyn Plummer et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Management of women with abnormal cervical cytology: treatment patterns and associated costs in England and Wales
P. Martin-Hirsch et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2007)
Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: An evaluation from multiple analytic perspectives
Ralph P. Insinga et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Clinical utility of atypical glandular cells (AGC) classification: Cytohistologic comparison and relationship to HPV results
Teresa P. Diaz-Montes et al.
GYNECOLOGIC ONCOLOGY (2007)
Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK
M. Kohli et al.
BRITISH JOURNAL OF CANCER (2007)
Model for assessing human papillomavirus vaccination strategies
Elamin H. Elbasha et al.
EMERGING INFECTIOUS DISEASES (2007)
Modeling human papillomavirus vaccine effectiveness: Quantifying the impact of parameter uncertainty
Nicolas Van de Velde et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
HPV type-distribution in women with and without cervical neoplastic diseases
Gary Clifford et al.
VACCINE (2006)
HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial
H. C. Kitchener et al.
BRITISH JOURNAL OF CANCER (2006)
Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: Mathematical modelling analyses
Ruanne V. Barnabas et al.
PLOS MEDICINE (2006)
Trends in sexually transmitted infections in general practice 1990-2000: population based study using data from the UK general practice research database
JA Cassell et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
A new method for the classification of invasive cervical cancer screening histories
Helen Bagnall et al.
JOURNAL OF MEDICAL SCREENING (2006)
Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors
G Danaei et al.
LANCET (2005)
A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica
PE Castle et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine
SJ Goldie et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Against which human papillomavirus types shall we vaccinate and screen?: The international perspective
N Muñoz et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
The predicted effect of changes in cervical screening practice in the UK: results from a modelling study
K Canfell et al.
BRITISH JOURNAL OF CANCER (2004)
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
DM Harper et al.
LANCET (2004)
A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine
SJ Goldie et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Long-term follow-up of patients following negative colposcopy: a new gold standard and its implications for cervical screening
PD Da Forno et al.
CYTOPATHOLOGY (2003)
Potential health and economic impact of adding a human papillomavirus vaccine to screening programs
SL Kulasingam et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Epidemiologic classification of human papillomavirus types associated with cervical cancer
N Muñoz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England
P Sasieni et al.
LANCET (2001)
Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review
K Nanda et al.
ANNALS OF INTERNAL MEDICINE (2000)
Share Paper
